Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|July 7, 2010
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brainGiselle Y Lopez, Zachary J Reitman, David Solomon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2011
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolomeZachary J Reitman, Genglin Jin, Edward D Karoly, et al.
Oncogene|September 23, 2023
Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastomaKevin J Tu, Connor E Stewart, Peter G Hendrickson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 29, 2025
An Explainable Deep Model for Risk Scoring and Accurate Radionecrosis Identification Following Brain Metastasis Stereotactic RadiosurgeryJingtong Zhao, Eugene Vaios, Evan Calabrese, et al.
Neoplasia (New York, N.Y.)|March 8, 2025
Combining the RCAS/tv-a retrovirus and CRISPR/Cas9 gene editing systems to generate primary mouse models of diffuse midline gliomaSophie R Wu, Julianne Sharpe, Joshua Tolliver, et al.
The Journal of Biological Chemistry|July 3, 2014
Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxiaZachary J Reitman, Christopher G Duncan, Ethan Poteet, et al.
Acta Neuropathologica Communications|March 25, 2023
Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like populationJoshua A Regal, María E Guerra García, Vaibhav Jain, et al.
Neuro-Oncology Practice|June 9, 2025
Seizure risk factors and management approaches in patients with brain metastasesEugene J Vaios, Spencer Maingi, Kristen Batich, et al.
Pageof 8